A
Alberta L. Warner
Researcher at University of California, Los Angeles
Publications - 40
Citations - 2962
Alberta L. Warner is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 15, co-authored 34 publications receiving 2521 citations. Previous affiliations of Alberta L. Warner include Veterans Health Administration & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
HIV Infection and the Risk of Acute Myocardial Infarction
Matthew S. Freiberg,Chung-Chou H. Chang,Lewis H. Kuller,Melissa Skanderson,Elliott Lowy,Kevin L. Kraemer,Adeel A. Butt,Matthew Bidwell Goetz,David A. Leaf,Krisann K. Oursler,David Rimland,Maria C. Rodriguez Barradas,Sheldon T. Brown,Cynthia Gibert,Kathy McGinnis,Kristina Crothers,Jason J. Sico,Heidi M. Crane,Alberta L. Warner,Stephen S. Gottlieb,John S. Gottdiener,Russell P. Tracy,Matthew J. Budoff,Courtney Watson,Kaku A. Armah,Donna Almario Doebler,Kendall Bryant,Amy C. Justice +27 more
TL;DR: Investigating whether HIV is associated with an increased risk of acute myocardial infarction after adjustment for all standard Framingham risk factors among a large cohort of HIV-positive and demographically and behaviorally similar uninfected veterans in care found infections with HIV are associated with a 50% increased risk beyond that explained by recognized risk factors.
Journal ArticleDOI
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation
Brian Olshansky,Lynda E. Rosenfeld,Alberta L. Warner,Allen J. Solomon,Gearoid O’Neill,Arjun D. Sharma,Edward V. Platia,Gregory K. Feld,Toshio Akiyama,Michael A. Brodsky,H. Leon Greene,Affirm Investigators +11 more
TL;DR: Rate control in AF is possible in the majority of patients with AF, and beta-blockers were the most effective drugs.
Journal ArticleDOI
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study.
Matthew S. Freiberg,Chung-Chou H. Chang,Melissa Skanderson,Olga V. Patterson,Scott L. DuVall,Cynthia Brandt,Kaku So-Armah,Ramachandran S. Vasan,Krisann K. Oursler,John S. Gottdiener,Stephen S. Gottlieb,David E. Leaf,Maria C. Rodriguez-Barradas,Russell P. Tracy,Cynthia L. Gibert,David Rimland,Roger Bedimo,Sheldon T. Brown,Matthew Bidwell Goetz,Alberta L. Warner,Kristina Crothers,Hilary A. Tindle,Charles Alcorn,Justin M. Bachmann,Amy C. Justice,Adeel A. Butt +25 more
TL;DR: Individuals who are infected with HIV have an increased risk of HFpEF, borderline HF pEF, and HFrEF compared with uninfected individuals, and future research should focus on prevention, risk stratification, and identification of the mechanisms for HFr EF and HFp EF in the HIV-infected population.
Journal ArticleDOI
HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction
Anne Lise Paisible,Chung-Chou H. Chang,Kaku So-Armah,Adeel A. Butt,David A. Leaf,Matthew J. Budoff,David Rimland,Roger Bedimo,Matthew Bidwell Goetz,Maria C. Rodriguez-Barradas,Heidi M. Crane,Cynthia L. Gibert,Sheldon T. Brown,Hilary A. Tindle,Alberta L. Warner,Charles Alcorn,Melissa Skanderson,Amy C. Justice,Matthew S. Freiberg +18 more
TL;DR: The prevalence of optimal cardiac health is low in this cohort and Preventing/reducing CVDRF burden may reduce excess AMI risk among HIV+ people.
Journal ArticleDOI
Contractility and stiffness of noninfarcted myocardium after coronary ligation in rats : effects of chronic angiotensin converting enzyme inhibition
TL;DR: It is suggested that angiotensin converting enzyme inhibition in the ratinfarct model of heart failure improves global cardiac performance via combined effects on myocardial function and the peripheral circulation.